tirzepatide side effects thyroid Effects: Common & Rare Reactions Explained Tirzepatide Side Effects: Risks, Safety,

In a recent survey, three-in-four respondents said they would prefer a oncedaily oral pill over a weekly injection of GLP-1s

When Novo Nordisk filed suit against Hims & Hers in early February, the case immediately drew attention as a high-stakes patent fight.

Results are less dramatic than injectable medications, but a manufacturer has signalled intent to apply for approval in the US.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective anti-glycemic and weight-loss medications with a strong safety record

Beyond their impact on weight, these medications have shown promise in ameliorating obesity-related health markers, including lowering blood pressure, improving lipid profiles, and enhancing glycemic control (Marso et al., 2016)

Viking Therapeutics has divulged dual agonists of GLP-1 and glucose-dependent insulinotropic receptor (GDIR) reported to be useful for the treatment of nonalcoholic fatty liver disease (NAFLD).